N. Acarin et al., DIFFERENT ANTIGANGLIOSIDE ANTIBODY PATTERN BETWEEN RELAPSING-REMITTING AND PROGRESSIVE MULTIPLE-SCLEROSIS, Acta neurologica Scandinavica, 93(2-3), 1996, pp. 99-103
Introduction - Multiple sclerosis (MS) is an autoimmune disorder, but
an unique antigen has not been found. Antiganglioside antibodies (AGA)
have been reported in MS, nevertheless, a clinical significance of AG
A in MS has not been established. The aims of this study were to study
AGA in sera of MS patients and to investigate relationships between A
GA and clinical course of MS. Material and methods - 42 patients with
MS who fulfilled the criteria of clinically definite disease (59% RRMS
, 21% SPMS, 20% PPMS), 89 patients with systemic lupus erythematosus a
nd 36 healthy controls were studied. A modification of previously desc
ribed ELISA techniques was used to estimate serum IgG and IgM anti-GM1
, asialoGM1 and anti-GD1a antibodies. Results - 47.6% of the patients
showed AGA reactivity. Anti-GM1 was found in 38% of MS patients, anti-
asialoGM1 in 23.8% and anti-GD1a in 33.3%. IgG was the isotype more co
mmonly found. A correlation between presence of AGA and progressive di
sease and between anti-GD1a and PPMS was found. Conclusions - The pres
ence of AGA in MS patients is elevated. In contrast with the results o
f others authors, a strong correlation between AGA and progressive dis
ease is showed in our study.